超声造影融合虚拟导航技术引导肝肿瘤消融治疗的疗效分析

Outcomes of percutaneous ablation guided by contrast-enhanced ultrasound fusion virtual navigation technology in treatment of hepatic tumors

  • 摘要:
      背景  实时影像虚拟导航系统(real-time virtual navigation system,RVS)是将超声实时动态成像和CT/MRI定位准确等优势结合起来,使其在治疗过程发挥更大作用的新方法。
      目的  探讨超声造影(contrast-enhanced ultrasound,CEUS)融合虚拟导航技术在高危部位和超声显示困难肝肿瘤经皮消融治疗中的临床应用价值。
      方法  回顾性分析解放军总医院第五医学中心2017年1月- 2018年12月收治的131例病理诊断或综合影像学诊断为肝癌患者的临床资料,对157个病灶进行超声造影与增强CT/MRI检查,其中邻近膈肌、大血管、心脏和胃肠等高危部位且常规超声显示困难的病灶(44例共53个病灶)纳入RVS-CEUS引导组,非高危部位且超声显示困难的病灶(36例共44个病灶)纳入CT引导组,高危部位且超声可显示的病灶(51例患者共60个病灶)纳入US引导组。
      结果  RVS-CEUS引导组44例患者的53个病灶超声和CT/MRI图像融合成功率为100%。RVS-CEUS引导组的完全消融率显著高于US引导组和CT引导组(96.23% vs 81.82%、81.67%,P<0.05),残留率低于US引导组和CT引导组(3.77% vs 18.33% 、18.18%,P<0.05),差异均有统计学意义;术后3个月复查,三组局部进展率差异无统计学意义(28.30% vs 36.67% vs 38.64%,P=0.507)。本研究的131例患者均未发生严重并发症和与治疗相关的死亡。
      结论  融合成像技术提高了肿瘤靶向消融的准确性和效率,对于既往热消融相对禁忌部位肝癌具有确切的临床应用价值,拓宽了经皮热消融治疗的适应证,提高了显像困难/高危部位肝癌病灶的检出率以及经皮热消融疑难部位肝肿瘤的准确性和安全性。

     

    Abstract:
      Background   Real-time virtual navigation system (RVS) combined with contrast-enhanced ultrasound is a new method that combines the advantages of real-time dynamic imaging of ultrasound and accurate positioning of CT/MRI, which makes it plays an important role in the local ablation therapies.
      Objective   To explore the value of using real-time virtual navigation system combined with contrast-enhanced ultrasound in percutaneous ablation for hepatic tumors located in high-risk or undetectable areas by conventional B-mode ultrasound.
      Methods   Clinical data about 131 patients with hepatic tumors diagnosed by pathology or imaging from January 2017 to December 2018 in the Fifth Medical Center of Chinese PLA General Hospital were retrospectively analyzed, and contrast-enhanced ultrasound and enhanced CT/MRI were performed on 157 lesions. The lesions that were located in high-risk areas at hepatic dome, near the macrovascular of liver, near the heart, or near the gastrointestinal tract and invisible in conventional B-mode ultrasound (44 cases with 53 lesions) were included in the RVS-CEUS guided group, and lesions in non-high-risk areas and invisible in conventional B-mode ultrasound (36 cases with 44 lesions) were included in the CT guided group, and the high-risk sites and conventional B-mode ultrasound visible lesions (51 cases with 60 lesions) were included in the US guided group.
      Results   The success rate of CEUS and CT/MRI image fusion of 53 lesions in 44 patients in the RVS-CEUS guided group was 100%. The complete response rate of the RVS-CEUS guided group was significantly higher than that of the other two groups (96.23% vs 81.82% and 81.67%, P<0.05), while the incomplete response rate was lower than that of the other two groups (3.77% vs 18.33% and 18.18%, P<0.05). After 3 months of follow-up, there was no significant difference in local tumor progression rate among the three groups after treatment (28.30% vs 36.67% vs 38.64%, P=0.507). No severe complications or treatment-related deaths occurred in 131 patients treated with ablation in this study.
      Conclusion   Real-time virtual navigation system improves the accuracy and efficiency of tumor targeted ablation, which has exact clinical application value for hepatic tumor in the relatively taboo parts of previous thermal ablation, broadens the indications of percutaneous thermal ablation treatment, improves the detection rate of lesions in difficult imaging and high-risk location and the accuracy and safety of hepatic tumor in difficult parts of percutaneous thermal ablation.

     

/

返回文章
返回